11.10.2013 18:12:00
|
Technical Study: Isis Pharma Inc., Santarus Inc., Community Health Systems Inc., and Quest Diagnostics Inc.
LONDON, October 11, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market posted significant gains on Thursday, October 10, 2013. All three benchmark indexes rose, with the Dow Jones Industrial Average finishing the day 2.18% higher, while the S&P 500 and the NASDAQ Composite gained 2.18% and 2.26% respectively. Shares in the healthcare sector ended on a mixed note, even as the broader rallied. The major movers in the sector included Isis Pharmaceuticals Inc. (NASDAQ: ISIS), Santarus Inc. (NASDAQ: SNTS), Community Health Systems Inc. (NYSE: CYH), and Quest Diagnostics Inc. (NYSE: DGX). AAAResearchReports.com free coverage on ISIS, SNTS, CYH, and DGX is available upon registration at:
http://www.aaaresearchreports.com/register/
Shares in Isis Pharmaceuticals Inc. surged 3.57% on Thursday, extending the gains from the previous trading session. The company's shares closed the day at $33.39 after fluctuating between $32.26 and $33.62 during the trading session. A total of 1.66 million shares were traded, which is above the daily average volume of 1.53 million. The company's shares have gained 5.60% in the previous one month and 5.33% in the last three months, compared to a gain of 0.51% and 2.42% in the S&P 500 during the respective periods. Furthermore, Isis Pharmaceuticals Inc.'s stock is trading above its 50-day and 200-day moving averages of $30.44 and $22.31, respectively. Download free technical research on ISIS by signing up at:
http://www.AAAResearchReports.com/ISIS101113.pdf
Santarus Inc.'s stock rose on Thursday, tracking gains in the broader market. The company's shares fluctuated between $21.63 and $22.20 before finishing the day 2.81% higher at $21.92. A total of 1.40 million shares were traded, which is below the daily average volume of 1.82 million. The company's stock has gained 0.18% in the previous three trading sessions, underperforming the S&P 500 which has gained 0.98% during the same period. Additionally, Santarus Inc.'s shares are trading above their 200-day moving average of $19.24. Register now and get access to free analysis on SNTS at:
http://www.AAAResearchReports.com/SNTS101113.pdf
Shares in Community Health Systems Inc. declined on Thursday, even as the broader market finished on a positive note. The company's shares finished the day at $42.84, down 2.26% from the previous day's closing price of $43.83. The company's shares oscillated between $42.25 and $44.26 during the trading session. A total of 2.60 million shares were traded, which is above the daily average volume of 1.95 million. Despite Thursday's losses, the company's stock has gained 9.76% in the previous one month, compared to a gain of 0.51% in the S&P 500 during the same period. Moreover, Community Health Systems Inc.'s stock is trading above its 50-day and 200-day moving averages of $41.68 and $42.58, respectively. Sign up and read our complimentary report on CYH at:
http://www.AAAResearchReports.com/CYH101113.pdf
Quest Diagnostics Inc.'s stock plummeted on Thursday, extending the losses from the previous trading session. The company's shares fluctuated between $57.45 and $59.89 before finishing the day 4.93% lower at $58.66. A total of 6.79 million shares were traded, which is significantly above the daily average volume of 1.40 million. The company's shares have declined 0.58% in the previous three months, underperforming the S&P 500 which has gained 2.42% during the same period. Furthermore, Quest Diagnostics Inc.'s stock is trading below its 50-day and 200-day moving averages of $60.35 and $59.10, respectively. The free report on DGX can be downloaded by signing up now at:
http://www.AAAResearchReports.com/DGXX101113.pdf
EDITOR NOTES:
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
http://www.AAAresearchreports.com
SOURCE AAA Research Reports
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Community Health Systems IncShs | 3,26 | 0,62% | |
Quest Diagnostics Inc. | 147,55 | -1,34% |